The association of grip strength from midlife onwards with all-cause and cause-specific mortality over 17 years of follow-up in the Tromsø Study
Permanent lenke
https://hdl.handle.net/10037/10603Dato
2016-08-25Type
Journal articleTidsskriftartikkel
Peer reviewed
Forfatter
Strand, Bjørn Heine; Cooper, Rachel; Bergland, Astrid; Jørgensen, Lone; Schirmer, Henrik; Skirbekk, Vegard; Emaus, NinaSammendrag
Background
Grip strength has consistently been found
to predict all-cause mortality rates. However, few studies
have examined cause-speci
fi
c mortality or tested age
differences in these associations.
Methods
In 1994, grip strength was measured in the
population-based Tromsø Study, covering the ages
50
–
80 years (N=6850). Grip strength was categorised
into
fi
fths, and as z-scores. In this cohort study, models
with all-cause mortality and deaths from speci
fi
c causes
as the outcome were performed, strati
fi
ed by sex and
age using Cox regression, adjusting for lifestyle-related
and health-related factors.
Results
During 17 years of follow-up, 2338
participants died. A 1 SD reduction in grip strength was
associated with HR=1.17 (95% CI 1.12 to 1.22) for all-
cause mortality in a model adjusted for age, gender and
body size. This association was similar across all age
groups, in men and women, and robust to adjustment
for a range of lifestyle-related and health-related factors.
Results for deaths due to cardiovascular disease (CVD),
respiratory diseases and external causes resembled those
for all-cause mortality, while for cancer, the association
was much weaker and not signi
fi
cant after adjustment
for lifestyle-related and health-related factors.
Conclusions
Weaker grip strength was associated with
increased all-cause mortality rates, with similar effects on
deaths due to CVD, respiratory disease and external
causes, while a much weaker association was observed
for cancer-related deaths. These associations were similar
in both genders and across age groups, which supports
the hypothesis that grip strength might be a biomarker
of ageing over the lifespan.